Symmetrical Intertriginous and Flexural Exanthema due to Bortezomib (a Proteasome Inhibitor) Given for Myeloma

Acta Derm Venereol. 2016 Nov 2;96(7):995-996. doi: 10.2340/00015555-2415.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Bortezomib / adverse effects*
  • Drug Eruptions*
  • Exanthema / chemically induced*
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Proteasome Inhibitors / adverse effects*

Substances

  • Antineoplastic Agents
  • Proteasome Inhibitors
  • Bortezomib